PSMD14 and osteosarcoma: Thus, these results suggested that PSMD14 knockdown inhibits the malignant biological behaviors of osteosarcoma-R cell lines and reverses the inhibitory impact of anlotinib on the resistant cells’ malignant biological behaviors.